Galactomannan in piperacillin-tazobactam: How much and to what extent?

被引：23
|
作者：
Machetti, M
Furfaro, E
Viscoli, C
机构：
[1] Natl Inst Canc Res, Infect Dis Unit, I-16132 Genoa, Italy
[2] Adv Biotechnol Ctr, Genoa, Italy
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2005年 / 49卷 / 09期
关键词：
D O I：
10.1128/AAC.49.9.3984-3985.2005
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：3984 / 3985
页数：2
相关论文
共 50 条
  • [41] ANTISTAPHYLOCOCCAL EFFICACY OF CEFEPIME, PIPERACILLIN-TAZOBACTAM, AND MEROPENEM
    Subedi, Bibidh
    Najia, Laila
    Pyles, Eric
    Ruiz, Arnaldo Lopez
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 337 - 337
  • [42] Piperacillin-tazobactam:: a β-lactam/β-lactamase inhibitor combination
    Gin, Alfred
    Dilay, Leanne
    Karlowsky, James A.
    Walkty, Andrew
    Rubinstein, Ethan
    Zhanel, George G.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2007, 5 (03) : 365 - 383
  • [43] Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies
    Adam, O
    Aupérin, A
    Wilquin, F
    Bourhis, JH
    Gachot, B
    Chachaty, E
    CLINICAL INFECTIOUS DISEASES, 2004, 38 (06) : 917 - 920
  • [44] Lack of evidence that false-positive Aspergillus galactomannan antigen test results are due to treatment with piperacillin-tazobactam
    Penack, O
    Schwartz, S
    Thiel, E
    Blau, IW
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (09) : 1401 - 1402
  • [45] Assessment of biliary excretion of piperacillin-tazobactam in humans
    Westphal, JF
    Brogard, JM
    CaroSampara, F
    Adloff, M
    Blickle, JF
    Monteil, H
    Jehl, F
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (08) : 1636 - 1640
  • [46] The use of piperacillin-tazobactam in neonatal and paediatric patients
    Wolf, Maria F.
    Simon, Arne
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (01) : 57 - 69
  • [47] Piperacillin-Tazobactam Allergies: An Exception to Usual Penicillin Allergy
    Wong, Jane C. Y.
    Au, Elaine Y. L.
    Yeung, Heather H. F.
    Lau, Chak-Sing
    Li, Philip Hei
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2021, 13 (02) : 284 - 294
  • [48] Piperacillin-Tazobactam: Extended Infusion Versus Continuous Infusion
    Messori, Andrea
    Tulli, Giorgio
    Caccese, Erminia
    Trippoli, Sabrina
    Marinai, Claudio
    CRITICAL CARE MEDICINE, 2018, 46 (07) : E725 - E725
  • [49] We need to optimize piperacillin-tazobactam dosing in critically ill patients-but how?
    Cotta, Menino Osbert
    Roberts, Jason A.
    Lipman, Jeffrey
    CRITICAL CARE, 2016, 20
  • [50] Pharmacoeconomic analysis of extended-infusion piperacillin-tazobactam
    Raja, Karan
    Patel, Ruben
    Patel, Mitesh
    Attalla, Mark
    Philips, Mona
    PHARMACOTHERAPY, 2017, 37 (12): : E126 - E126
12345